Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (71-80 of 685) with videos related to

Pageof 69
Sort By:
Scientific Reports|July 29, 2022
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenograftsLicai Huang, Jing Wang, Bingliang Fang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2025
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic AdvancesLorenzo Guidi, Julian Etessami, Carmine Valenza, et al.
Clinical Chemistry|November 13, 2012
The impact of tumor heterogeneity on patient treatment decisionsCarol J Farhangfar, Funda Meric-Bernstam, John Mendelsohn, et al.
Cancer Science|March 31, 2011
Nanomedicine in cancer therapy: innovative trends and prospectsElvin Blanco, Angela Hsiao, Aman P Mann, et al.
The Lancet. Oncology|February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careDebashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Molecular Oncology|November 11, 2011
Molecular-targeted nanotherapies in cancer: enabling treatment specificityElvin Blanco, Angela Hsiao, Guillermo U Ruiz-Esparza, et al.
Nature Reviews. Clinical Oncology|October 16, 2023
Molecular tumour boards - current and future considerations for precision oncologyApostolia M Tsimberidou, Michael Kahle, Henry Hiep Vo, et al.
BMC Genomics|July 1, 2016
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer typesTenghui Chen, Zixing Wang, Wanding Zhou, et al.
Cancer|February 13, 2008
Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancerElmer V Bernstam, Muhammad F Walji, Smitha Sagaram, et al.
JCO Precision Oncology|October 26, 2019
Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With <i>AKT1_E17K</i> MutationBranko Cuglievan, Vivek Subbiah, Huamin Wang, et al.
Pageof 69

Showing results (71-80 of 685) with videos related to

Sort By:
Pageof 69
Scientific Reports|July 29, 2022
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenograftsLicai Huang, Jing Wang, Bingliang Fang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2025
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic AdvancesLorenzo Guidi, Julian Etessami, Carmine Valenza, et al.
Clinical Chemistry|November 13, 2012
The impact of tumor heterogeneity on patient treatment decisionsCarol J Farhangfar, Funda Meric-Bernstam, John Mendelsohn, et al.
Cancer Science|March 31, 2011
Nanomedicine in cancer therapy: innovative trends and prospectsElvin Blanco, Angela Hsiao, Aman P Mann, et al.
The Lancet. Oncology|February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careDebashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.
Molecular Oncology|November 11, 2011
Molecular-targeted nanotherapies in cancer: enabling treatment specificityElvin Blanco, Angela Hsiao, Guillermo U Ruiz-Esparza, et al.
Nature Reviews. Clinical Oncology|October 16, 2023
Molecular tumour boards - current and future considerations for precision oncologyApostolia M Tsimberidou, Michael Kahle, Henry Hiep Vo, et al.
BMC Genomics|July 1, 2016
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer typesTenghui Chen, Zixing Wang, Wanding Zhou, et al.
Cancer|February 13, 2008
Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancerElmer V Bernstam, Muhammad F Walji, Smitha Sagaram, et al.
JCO Precision Oncology|October 26, 2019
Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With <i>AKT1_E17K</i> MutationBranko Cuglievan, Vivek Subbiah, Huamin Wang, et al.
Pageof 69